Home/Filings/4/0000899243-22-038602
4//SEC Filing

TEPPER ROBERT I 4

Accession 0000899243-22-038602

CIK 0001680581other

Filed

Dec 14, 7:00 PM ET

Accepted

Dec 15, 4:30 PM ET

Size

13.2 KB

Accession

0000899243-22-038602

Insider Transaction Report

Form 4
Period: 2022-12-13
Transactions
  • Other

    Common Stock

    2022-12-132,000,0001,962,202 total
Holdings
  • Common Stock

    (indirect: See footnote)
    2,343,154
  • Common Stock

    156,189
Transactions
  • Other

    Common Stock

    2022-12-132,000,0001,962,202 total
Holdings
  • Common Stock

    156,189
  • Common Stock

    (indirect: See footnote)
    2,343,154
Transactions
  • Other

    Common Stock

    2022-12-132,000,0001,962,202 total
Holdings
  • Common Stock

    156,189
  • Common Stock

    (indirect: See footnote)
    2,343,154
Transactions
  • Other

    Common Stock

    2022-12-132,000,0001,962,202 total
Holdings
  • Common Stock

    (indirect: See footnote)
    2,343,154
  • Common Stock

    156,189
Footnotes (4)
  • [F1]On December 13, 2022, Third Rock Ventures III, L.P. ("TRV III") distributed for no consideration, 2,000,000 shares of Common Stock of the Issuer (the "Shares") to its limited partners and to Third Rock Ventures GP III, L.P. ("TRV GP III"), the general partner of TRV III, representing each such partner's pro rata interest in such Shares. On the same date, TRV GP III distributed, for no consideration, the Shares it received in the distribution by TRV III to its partners, representing each such partner's pro rata interest in such Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Securities Exchange Act of 1934, as amended.
  • [F2]These shares are directly held by TRV III. The general partner of TRV III is TRV GP III. The general partner of TRV GP III is TRV GP III, LLC ("TRV GP III LLC"). The individual manager of TRV GP III LLC is Dr. Robert Tepper ("Tepper"). Each of TRV GP III, TRV GP III LLC and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares.
  • [F3]These shares are directly held by Third Rock Ventures IV, L.P. ("TRV IV"). The general partner of TRV IV is Third Rock Ventures GP IV, L.P. ("TRV GP IV"). The general partner of TRV GP IV is TRV GP IV, LLC ("TRV GP IV LLC"). Each of TRV GP IV and TRV GP IV LLC disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it is the beneficial owner of such shares. Each of the reporting persons disclaims the existence of a Section 13(d) "group" as between the TRV III related parties and the TRV IV related parties and this report shall not be deemed an admission that any of such parties is or may be part of such a group with any of the other parties.
  • [F4]The shares are directly held by Tepper. Includes Shares received in the distributions described in footnote (1) above.

Issuer

Fulcrum Therapeutics, Inc.

CIK 0001680581

Entity typeother

Related Parties

1
  • filerCIK 0001192595

Filing Metadata

Form type
4
Filed
Dec 14, 7:00 PM ET
Accepted
Dec 15, 4:30 PM ET
Size
13.2 KB